These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27342108)

  • 1. Inter-Laboratory Evaluation of a Next-Generation Sequencing Panel for Acute Myeloid Leukemia.
    Haslam K; Catherwood MA; Dobbin E; Sproul A; Langabeer SE; Mills KI
    Mol Diagn Ther; 2016 Oct; 20(5):457-61. PubMed ID: 27342108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.
    Au CH; Wa A; Ho DN; Chan TL; Ma ES
    Diagn Pathol; 2016 Jan; 11():11. PubMed ID: 26796102
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Ng CWS; Kosmo B; Lee PL; Lee CK; Guo J; Chen Z; Chiu L; Lee HK; Ho S; Zhou J; Lin M; Tan KML; Ban KHK; Tan TW; Chng WJ; Yan B
    J Clin Pathol; 2018 Jun; 71(6):522-531. PubMed ID: 29180507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of FLT3 internal tandem duplication in targeted, short-read-length, next-generation sequencing data.
    Spencer DH; Abel HJ; Lockwood CM; Payton JE; Szankasi P; Kelley TW; Kulkarni S; Pfeifer JD; Duncavage EJ
    J Mol Diagn; 2013 Jan; 15(1):81-93. PubMed ID: 23159595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next-generation sequencing-based multigene mutational screening for acute myeloid leukemia using MiSeq: applicability for diagnostics and disease monitoring.
    Luthra R; Patel KP; Reddy NG; Haghshenas V; Routbort MJ; Harmon MA; Barkoh BA; Kanagal-Shamanna R; Ravandi F; Cortes JE; Kantarjian HM; Medeiros LJ; Singh RR
    Haematologica; 2014 Mar; 99(3):465-73. PubMed ID: 24142997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Next-Generation Sequencing in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia Aids Diagnosis in Challenging Cases and Identifies Frequent Spliceosome Mutations in Transformed Acute Myeloid Leukemia.
    Reinig E; Yang F; Traer E; Arora R; Brown S; Rattray R; Braziel R; Fan G; Press R; Dunlap J
    Am J Clin Pathol; 2016 Apr; 145(4):497-506. PubMed ID: 27124934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Landscape of Acute Myeloid Leukemia Interrogated by Next-generation Sequencing: A Large Cancer Center Experience.
    Hussaini MO; Mirza AS; Komrokji R; Lancet J; Padron E; Song J
    Cancer Genomics Proteomics; 2018; 15(2):121-126. PubMed ID: 29496691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitive NPM1 Mutation Quantitation in Acute Myeloid Leukemia Using Ultradeep Next-Generation Sequencing in the Diagnostic Laboratory.
    Blombery P; Jones K; Doig K; Ryland G; McBean M; Thompson E; Yannakou CK; Westerman D
    Arch Pathol Lab Med; 2018 May; 142(5):606-612. PubMed ID: 29425073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-exome sequencing reveals the spectrum of gene mutations and the clonal evolution patterns in paediatric acute myeloid leukaemia.
    Shiba N; Yoshida K; Shiraishi Y; Okuno Y; Yamato G; Hara Y; Nagata Y; Chiba K; Tanaka H; Terui K; Kato M; Park MJ; Ohki K; Shimada A; Takita J; Tomizawa D; Kudo K; Arakawa H; Adachi S; Taga T; Tawa A; Ito E; Horibe K; Sanada M; Miyano S; Ogawa S; Hayashi Y
    Br J Haematol; 2016 Nov; 175(3):476-489. PubMed ID: 27470916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases.
    Ok CY; Patel KP; Garcia-Manero G; Routbort MJ; Fu B; Tang G; Goswami M; Singh R; Kanagal-Shamanna R; Pierce SA; Young KH; Kantarjian HM; Medeiros LJ; Luthra R; Wang SA
    Leuk Res; 2015 Mar; 39(3):348-54. PubMed ID: 25573287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspective on how to approach molecular diagnostics in acute myeloid leukemia and myelodysplastic syndromes in the era of next-generation sequencing.
    Kohlmann A; Bacher U; Schnittger S; Haferlach T
    Leuk Lymphoma; 2014 Aug; 55(8):1725-34. PubMed ID: 24144312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Analytical Validation of a DNA Dual-Strand Approach for the US Food and Drug Administration-Approved Next-Generation Sequencing-Based Praxis Extended RAS Panel for Metastatic Colorectal Cancer Samples.
    Udar N; Iyer A; Porter M; Haigis R; Smith S; Dhillon S; Meier K; Ward D; Lu J; Wenz P; Buchner L; Dunn T; Wise A; Mueller A; Gutekunst K
    J Mol Diagn; 2020 Feb; 22(2):159-178. PubMed ID: 31837434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Method for Next-Generation Sequencing of Paired Diagnostic and Remission Samples to Detect Mitochondrial DNA Mutations Associated with Leukemia.
    Pagani IS; Kok CH; Saunders VA; Van der Hoek MB; Heatley SL; Schwarer AP; Hahn CN; Hughes TP; White DL; Ross DM
    J Mol Diagn; 2017 Sep; 19(5):711-721. PubMed ID: 28732215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-tailored analysis of minimal residual disease in acute myeloid leukemia using next-generation sequencing.
    Malmberg EB; Ståhlman S; Rehammar A; Samuelsson T; Alm SJ; Kristiansson E; Abrahamsson J; Garelius H; Pettersson L; Ehinger M; Palmqvist L; Fogelstrand L
    Eur J Haematol; 2017 Jan; 98(1):26-37. PubMed ID: 27197529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurable residual disease monitoring for patients with acute myeloid leukemia following hematopoietic cell transplantation using error corrected hybrid capture next generation sequencing.
    Balagopal V; Hantel A; Kadri S; Steinhardt G; Zhen CJ; Kang W; Wanjari P; Ritterhouse LL; Stock W; Segal JP
    PLoS One; 2019; 14(10):e0224097. PubMed ID: 31658273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathology Consultation on Gene Mutations in Acute Myeloid Leukemia.
    Ziai JM; Siddon AJ;
    Am J Clin Pathol; 2015 Oct; 144(4):539-54. PubMed ID: 26386075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Utility of a Next-Generation Sequencing Panel for Acute Myeloid Leukemia Diagnostics.
    Alonso CM; Llop M; Sargas C; Pedrola L; Panadero J; Hervás D; Cervera J; Such E; Ibáñez M; Ayala R; Martínez-López J; Onecha E; de Juan I; Palanca S; Martínez-Cuadrón D; Rodríguez-Veiga R; Boluda B; Montesinos P; Sanz G; Sanz MA; Barragán E
    J Mol Diagn; 2019 Mar; 21(2):228-240. PubMed ID: 30576870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of an integrated clinical workflow for targeted next-generation sequencing of low-quality tumor DNA using a 51-gene enrichment panel.
    Choudhary A; Mambo E; Sanford T; Boedigheimer M; Twomey B; Califano J; Hadd A; Oliner KS; Beaudenon S; Latham GJ; Adai AT
    BMC Med Genomics; 2014 Nov; 7():62. PubMed ID: 25395014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variant allele frequencies do not correlate well with myeloblast counts in a clinically validated gene sequencing panel for routine acute myeloid leukemia workup.
    Toth LN; Green D; Peterson J; Deharvengt SJ; de Abreu FB; Loo EY
    Leuk Lymphoma; 2019 Oct; 60(10):2415-2422. PubMed ID: 30997856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parallel targeted next generation sequencing of childhood and adult acute myeloid leukemia patients reveals uniform genomic profile of the disease.
    Marjanovic I; Kostic J; Stanic B; Pejanovic N; Lucic B; Karan-Djurasevic T; Janic D; Dokmanovic L; Jankovic S; Vukovic NS; Tomin D; Perisic O; Rakocevic G; Popovic M; Pavlovic S; Tosic N
    Tumour Biol; 2016 Oct; 37(10):13391-13401. PubMed ID: 27460089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.